acp obesity guidelines
3 Hidden Dangers in the New Semaglutide Rules
In 2023, semaglutide was the 157th most commonly prescribed medication in the United States, with over 3 million prescriptions. The new ACP guidelines place semaglutide and tirzepatide at the top of the obesity ladder, yet they also introduce hidden clinical and administrative pitfalls that most physicians overlook. Medical Disclaimer: This